Cargando…
Neurotensin Branched Peptide as a Tumor-Targeting Agent for Human Bladder Cancer
Despite recent advances in multimodal therapy, bladder cancer still ranks ninth in worldwide cancer incidence. New molecules which might improve early diagnosis and therapeutic efficiency for tumors of such high epidemiological impact therefore have very high priority. In the present study, the tetr...
Autores principales: | Brunetti, Jlenia, Falciani, Chiara, Lelli, Barbara, Minervini, Andrea, Ravenni, Niccolò, Depau, Lorenzo, Siena, Giampaolo, Tenori, Eleonora, Menichetti, Stefano, Pini, Alessandro, Carini, Marco, Bracci, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423026/ https://www.ncbi.nlm.nih.gov/pubmed/25984525 http://dx.doi.org/10.1155/2015/173507 |
Ejemplares similares
-
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug
por: Brunetti, Jlenia, et al.
Publicado: (2015) -
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells
por: Bracci, Luisa, et al.
Publicado: (2018) -
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate
por: Depau, Lorenzo, et al.
Publicado: (2017) -
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe
por: Brunetti, Jlenia, et al.
Publicado: (2016) -
A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment
por: Brunetti, Jlenia, et al.
Publicado: (2020)